Skip to main content
. 2023 Dec 15;15(12):6849–6857.

Table 4.

Comparison of adverse effects of the two treatment modalities

Adverse effect Dry mouth Dysuria Vertigo Xerophthalmia Local inflammation Enlarged breasts Vaginal bleeding Overall incidence
Tolterodine (n = 30) 8 3 2 1 2 0 0 53%
Intravaginal Estrogen (n = 28) 0 1 1 0 3 0 2 25%